25 Essential Tremor Clinical Trials in Bethesda, MD (2026)

Q: How do I join a clinical trial in Bethesda?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you.

Recruiting Essential Tremor Studies in Bethesda

NCT01143454Recruiting

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Background: \- Researchers are interested in studying individuals who have known or suspected metabolic, inflammatory or genetic diseases that may put them at a high risk for heart diseases or diseas...

Bethesda, MD5,000 participantsNational Heart, Lung, and Blood Institute (NHLBI)

View Study Details

NCT00018057Recruiting

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Study Description: This study examines relations between neurocognitive and clinical features of pediatric anxiety disorders. The study uses neuro-cognitive tasks, functional magnetic resonance imagi...

Bethesda, MDPHASE23,500 participantsNational Institute of Mental Health (NIMH)

View Study Details

NCT05007990Recruiting

Caregiving Networks Across Disease Context and the Life Course

Background: In the U.S., about 53 million informal, unpaid caregivers provide care to a person who is ill, is disabled, or has age-related loss of function. These caregivers may be adult children, sp...

Bethesda, MD2,800 participantsNational Human Genome Research Institute (NHGRI)

View Study Details

NCT05111925Recruiting

Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement

The purpose of this study is to develop comprehensive and efficient pre- and post- musculoskeletal injury (MSKI) risk assessments for Service members, incorporating both objective and subjective measu...

Bethesda, MD2,690 participantsWomack Army Medical Center

View Study Details

NCT02471287Recruiting

Genetics of Inherited Eye Disease

Background: Research has identified some of the genes involved in inherited eye diseases. But for many of these diseases, the genes are not yet known. Researchers want to try to find these genes. The...

Bethesda, MD1,500 participantsNational Eye Institute (NEI)

View Study Details

NCT00001987Recruiting

Genetic Studies of Insulin and Diabetes

The study will allow researchers to obtain blood, plasma, DNA, and RNA for genetic studies of insulin. There will be a focus on the causes of insulin resistance and diabetes mellitus. Insulin is a hor...

Bethesda, MD1,200 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

View Study Details

NCT02890342Recruiting

Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia

Background: People s bodies need to break down food into the chemicals. These chemicals are used for energy and growth. Some people cannot process all chemicals very well. Too much of some chemicals ...

Bethesda, MD1,045 participantsNational Human Genome Research Institute (NHGRI)

View Study Details

NCT01432847Recruiting

Cell Collection to Study Eye Diseases

Background: \- Best Vitelliform Dystrophy (Best disease), Late-Onset Retinal Degeneration (L-ORD), and Age-Related Macular Degeneration (AMD) all affect the retina, the light sensing area at the back...

Bethesda, MD930 participantsNational Eye Institute (NEI)

View Study Details

NCT03087253Recruiting

The LD Lync Study - Natural History Study of Lipodystrophy Syndromes

Genetic lipodystrophy syndromes are extremely rare, orphan diseases with overall estimated prevalence of less than 2,000 in the United States. These rare disorders characterized by selective loss of a...

Bethesda, MD500 participantsUniversity of Michigan

View Study Details

NCT07502586Recruiting

Turner Syndrome: Genetic Considerations

Background: Turner syndrome (TS) is a rare genetic condition. It happens when a person is born missing all or part of an X sex chromosome. People with TS can have heart defects, short stature, autoim...

Bethesda, MD500 participantsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

View Study Details

NCT05738824Recruiting

Natural History of Inflammatory Muscle Diseases

Objective: To collect information and biospecimens (such as blood, muscle, and skin samples) that will be used to research causes and treatments of inflammatory muscle diseases. Eligibility: People...

Bethesda, MD500 participantsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

View Study Details

NCT01174121Recruiting

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Background: The NCI Surgery Branch has developed an experimental therapy that involves taking white blood cells from patients' tumors, growing them in the laboratory in large numbers, and then giving...

Bethesda, MDPHASE2332 participantsNational Cancer Institute (NCI)

View Study Details

NCT05605574Recruiting

Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant

Background: For adolescent and young adults (AYAs) with certain life-threatening illnesses, hematopoietic stem cell transplant (HSCT) provides the best chance for cure and survival. HSCT is a life-sa...

Bethesda, MDNA222 participantsNational Cancer Institute (NCI)

View Study Details

NCT05122728Recruiting

Post-Concussion Musculoskeletal Injury Risks

Musculoskeletal injuries (MSKI) and traumatic brain injury (TBI) are the signature injuries of the ongoing military conflicts. MSKI affect 800,000 Service Members annually and TBI have impacted more t...

Bethesda, MD148 participantsWalter Reed National Military Medical Center

View Study Details

NCT03750227Recruiting

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors

This phase III trial studies the side effects and how well stereotactic radiosurgery (SRS) works before or after surgery in patients with tumors that has spread to the brain or that can be removed by ...

Bethesda, MDPHASE3140 participantsMayo Clinic

View Study Details

NCT07046819Recruiting

Tirzepatide in MetALD

Background: People with alcohol use disorder (AUD) often develop metabolic alcohol-associated liver disease (MetALD). MetALD is a term for the heart, liver, obesity, and other issues that can accompa...

Bethesda, MDPHASE2120 participantsNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

View Study Details

NCT05031507Recruiting

Study of Skeletal Disorders

Background: There are 461 conditions that affect the bones (skeletal disorders). Many of these are not well understood and do not have any specific treatments. Researchers want to collect more data a...

Bethesda, MD100 participantsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

View Study Details

NCT05286814Recruiting

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Background: One way to treat liver cancer is to deliver chemotherapy drugs only to the liver (and not to the whole body). Researchers want to see if adding the drug PDS01ADC can improve the treatment...

Bethesda, MDPHASE270 participantsNational Cancer Institute (NCI)

View Study Details

NCT06253494Recruiting

Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

Background: Endometrial cancer (EC) of the uterus is becoming more common in the US. Sometimes EC often has increased levels of a protein called HER2. Cancers with HER2 tend to be more aggressive and...

Bethesda, MDPHASE160 participantsNational Cancer Institute (NCI)

View Study Details

NCT06149481Recruiting

Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

Background: Each year, more than 32,000 people in the United States are diagnosed with colorectal cancer that has returned or progressed after treatment and spread to other organs. This is called met...

Bethesda, MDPHASE160 participantsNational Cancer Institute (NCI)

View Study Details

NCT05687110Recruiting

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

This phase I trial tests the safety, side effects, and best dose of novobiocin in treating cancer patients with alterations in deoxyribonucleic acid (DNA) repair genes. Novobiocin is an antibiotic tha...

Bethesda, MDPHASE143 participantsNational Cancer Institute (NCI)

View Study Details

NCT06093867Recruiting

Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation

Background: Stem cell transplants (called hematopoietic stem cell transplantation, or HSCT) are used to treat various diseases. But when the cells for this procedure are donated by someone other than...

Bethesda, MD40 participantsNational Heart, Lung, and Blood Institute (NHLBI)

View Study Details

NCT07649317Recruiting

Ketoconazole Effects on the Daily Cortisol Rhythm in Mild Autonomous Cortisol Secretion

Background: Cortisol is a hormone in the blood. Cortisol levels normally go down at night and up in the morning. Mild autonomous cortisol secretion (MACS) is a disease in which the body makes too muc...

Bethesda, MDPHASE136 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

View Study Details

NCT05711615Recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

This phase I trial tests the safety, side effects, and best dose of combination therapy with liposomal doxorubicin and peposertib in treating patients with sarcoma that has spread from where it first ...

Bethesda, MDPHASE130 participantsNational Cancer Institute (NCI)

View Study Details

NCT05642455Recruiting

SPEARHEAD-3 Pediatric Study

This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers....

Bethesda, MDPHASE120 participantsAdaptimmune

View Study Details

About Essential Tremor Clinical Trials in Bethesda

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 25 essential tremor clinical trials recruiting participants in Bethesda, MD. These studies are seeking a combined 21,586 participants. Research is being sponsored by National Heart, Lung, and Blood Institute (NHLBI), National Institute of Mental Health (NIMH), National Human Genome Research Institute (NHGRI) and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in Bethesda — FAQ

Are there essential tremor clinical trials in Bethesda?

Yes, there are 25 essential tremor clinical trials currently recruiting in Bethesda, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bethesda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.

Are clinical trials in Bethesda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 25 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated September 2, 2026 from ClinicalTrials.gov